GPR55
GPR55 is a G protein-coupled receptor that in humans is encoded by the GPR55 gene. It is widely distributed throughout the body, with high expression levels in the adrenal gland, gastrointestinal tract, spleen, and endocrine glands. GPR55 has been implicated in a variety of physiological and pathological processes, including pain perception, bone development, and regulation of energy balance.
Function[edit | edit source]
GPR55 is activated by a variety of lipid ligands, including lysophosphatidylinositol (LPI) and various cannabinoids. Upon activation, it can stimulate several different intracellular signaling pathways, including those involving phospholipase C, calcium mobilization, and mitogen-activated protein kinases.
In the central nervous system, GPR55 has been implicated in the modulation of neuronal excitability and synaptic transmission. In the peripheral nervous system, it appears to play a role in the regulation of nociception and inflammation.
Clinical significance[edit | edit source]
Alterations in GPR55 signaling have been associated with a variety of diseases, including cancer, neurodegenerative diseases, and metabolic disorders. For example, overexpression of GPR55 has been observed in several types of cancer, including breast cancer, prostate cancer, and pancreatic cancer, and has been linked to increased cell proliferation and tumor growth.
In the context of neurodegenerative diseases, GPR55 has been implicated in the regulation of neuroinflammation and neuroprotection. In metabolic disorders, alterations in GPR55 signaling have been linked to abnormalities in glucose homeostasis and energy balance.
Research[edit | edit source]
Given its potential involvement in a variety of diseases, GPR55 is currently the subject of intense research. Several pharmacological agents that selectively target GPR55 are being developed and tested for their potential therapeutic effects.
See also[edit | edit source]
References[edit | edit source]
This GPCR-related article is a stub. You can help WikiMD by expanding it.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
